288 related articles for article (PubMed ID: 8850108)
21. [Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis ].
Golán L; Simek S; Linhart A; Cahlík T; Palecek T; Lubanda JC; Korínek J; Beran S; Aschermann M
Vnitr Lek; 2003 Feb; 49(2):97-102. PubMed ID: 12728575
[TBL] [Abstract][Full Text] [Related]
22. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Ferrari R;
Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
[TBL] [Abstract][Full Text] [Related]
23. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
Møller JE; Dahlström U; Gøtzsche O; Lahiri A; Skagen K; Andersen GS; Egstrup K;
Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
[TBL] [Abstract][Full Text] [Related]
24. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
[TBL] [Abstract][Full Text] [Related]
25. Integrating cost-effectiveness evidence into clinical practice guidelines in Australia for acute myocardial infarction.
Antioch KM; Jennings G; Botti M; Chapman R; Wulfsohn V
Eur J Health Econ; 2002; 3(1):26-39. PubMed ID: 15609115
[TBL] [Abstract][Full Text] [Related]
26. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG
Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514
[TBL] [Abstract][Full Text] [Related]
27. Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German Multicenter Study on the Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction (ECCE).
Kleber FX; Reindl I; Wenzel M; Rodewyk P; Beil S; Kosloswki B; Doering W; Sabin GV; Hinzmann S; Winter UJ
Herz; 1993 Dec; 18 Suppl 1():424-9. PubMed ID: 8125422
[TBL] [Abstract][Full Text] [Related]
28. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation.
Weintraub WS; Mahoney EM; Lamy A; Culler S; Yuan Y; Caro J; Gabriel S; Yusuf S;
J Am Coll Cardiol; 2005 Mar; 45(6):838-45. PubMed ID: 15766816
[TBL] [Abstract][Full Text] [Related]
29. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
[TBL] [Abstract][Full Text] [Related]
30. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
31. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M
Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of ramipril in heart failure after myocardial infarction. Economic evaluation of the Acute Infarction Ramipril Efficacy (AIRE) study for Germany from the perspective of Statutory Health Insurance.
Schädlich PK; Huppertz E; Brecht JG
Pharmacoeconomics; 1998 Dec; 14(6):653-69. PubMed ID: 10346417
[TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.
Newby LK; Eisenstein EL; Califf RM; Thompson TD; Nelson CL; Peterson ED; Armstrong PW; Van de Werf F; White HD; Topol EJ; Mark DB
N Engl J Med; 2000 Mar; 342(11):749-55. PubMed ID: 10717009
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study.
de Pouvourville G; Solesse A; Beillat M
Arch Cardiovasc Dis; 2008 Sep; 101(9):515-21. PubMed ID: 19041835
[TBL] [Abstract][Full Text] [Related]
35. [Captopril in the treatment of congestive heart failure in acute myocardial infarct].
Svejda J; Václavík P; Kopal V
Vnitr Lek; 1993 Apr; 39(4):340-4. PubMed ID: 8351861
[TBL] [Abstract][Full Text] [Related]
36. Postmyocardial infarction patients: experience from the SAVE trial.
Connors KF; Lamas GA
Am J Crit Care; 1995 Jan; 4(1):23-8. PubMed ID: 7894551
[TBL] [Abstract][Full Text] [Related]
37. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure.
Paul SD; Kuntz KM; Eagle KA; Weinstein MC
Arch Intern Med; 1994 May; 154(10):1143-9. PubMed ID: 8185426
[TBL] [Abstract][Full Text] [Related]
38. [Is the reduction of the plasma levels of endothelin in the acute and sub-acute stage of myocardial infarct one of the beneficial effects of early treatment with ace inhibitors?].
Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Longo AM; Alessi V; D'Amato M; Manusia F; Magatti MF
G Ital Cardiol; 1996 Jun; 26(6):673-80. PubMed ID: 8803588
[TBL] [Abstract][Full Text] [Related]
39. Economic aspects of captopril treatment.
Tsevat J; Pfeffer MA; Goldman L; Lee TH
Eur Heart J; 1997 Jan; 18(1):165. PubMed ID: 9049528
[No Abstract] [Full Text] [Related]
40. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Pfeffer MA; McMurray JJ; Velazquez EJ; Rouleau JL; Køber L; Maggioni AP; Solomon SD; Swedberg K; Van de Werf F; White H; Leimberger JD; Henis M; Edwards S; Zelenkofske S; Sellers MA; Califf RM;
N Engl J Med; 2003 Nov; 349(20):1893-906. PubMed ID: 14610160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
